Furthermore, an analysis of 202 patients with advanced NSCLC revealed that high TUBB3 expression was found more often in patients with adenocarcinoma histology, large cell carcinoma histology, diagnosis at a younger age (<59 years) and higher stage disease at diagnosis (stage IV vs. III) (14,15). The gene discussed is TUBB3; the disease is adenocarcinoma.